Dr. Kathleen Schmainda Receives Five-Year, $2.75 Million NIH/NCI U01 Grant
Kathleen Schmainda, PhD, MCW professor of Biophysics, has been awarded a five-year, $2.75 million NIH/NCI U01 grant to develop quantitative magnetic resonance imaging (MRI) technologies that provide earlier indications of brain tumor treatment response than what is currently available.
The studies will leverage Dr. Schmainda’s patented work in perfusion MRI technologies along with newer biomarkers to more precisely identify tumor burden and incorporate the latest advances in artificial intelligence. She is joined by an expert team of co-investigators including Dr. Jennifer Connelly, associate professor of neurology at MCW; Dr. Christopher Kleefisch, assistant professor of radiology at MCW; Dr. Brent Logan, professor of biostatistics at MCW; Dr. Jerrold Boxerman, associate professor of diagnostic imaging at Brown University–Rhode Island Hospital; and industrial partner Imaging Biometrics LLC, a subsidiary of IQ-AI Ltd.
Foundational to this effort are the members of Dr. Schmainda’s lab, which include Dr. Mona Al-Gizawiy, Melissa Prah, and Cathy Marszalkowski in the Department of Biophysics as well as biomedical engineering graduate student Robert Wujek.